Patents Assigned to PHARMASENS AG
  • Patent number: 11166660
    Abstract: An improved, injection or blood removal device for intravenous access has a port with a septum at the exterior end of an intravenous catheter, a coupling element having an adhesive surface for securing attachment onto the skin, an injection or blood sampling unit, a connecting cannula piercing the septum of the port, and means to secure functional assembly. Attachment of the device to the skin covering or close to the intravenous puncture site and without long communicating tubes allows ambulant injection of drugs or measuring of concentration-time profiles of exogenous and endogenous analytes to improve treatment modalities on an individualized basis.
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: November 9, 2021
    Assignee: PHARMASENS AG
    Inventors: Paul Hadváry, Hansjörg Tschirky
  • Patent number: 10478550
    Abstract: In a device for ambulatory wearing by the patient containing a pump for delivery of injection fluid or for removal of analysis fluid, the drive motor for the mechanically driven pump system is a Lavet-type stepper motor of small size designed for having a high mechanical power and low peak current requirement. Using this Lavet-type motor for syringe-type or peristaltic preferably patch-type pumps high infusion rates needed for e.g. bolus insulin injection or the delivery of therapeutic antibodies are achieved, and important safety features can be easily and reliably controlled, manufacturing costs get significantly reduced, and the overall size and weight of the device becomes smaller, for patient convenience.
    Type: Grant
    Filed: August 26, 2014
    Date of Patent: November 19, 2019
    Assignee: PHARMASENS AG
    Inventors: Paul Hadvary, Rudolf Dinger, Hansjorg Tschirky
  • Patent number: 10420488
    Abstract: An improved diagnostic analyte monitoring device has partially retractable hollow guide needles for the intradermal placement of diagnostic elements fixedly connected to measuring means within this device obviating the need to remove the guide needle and to connect the diagnostic elements to measuring means after placement into the skin. A flexible surface adhering to the skin serves for the subcutaneous implantation of the diagnostic elements within the guide needles and partial retraction of the guide needles exposes the active surface to body fluid, actuated by means designed for easy handling and safe operation. Concentration-time profiles of endogenous and exogenous analytes measured with the device are used to improve drug treatment modalities on an individualized basis.
    Type: Grant
    Filed: September 16, 2011
    Date of Patent: September 24, 2019
    Assignee: PHARMASENS AG
    Inventors: Paul Hadváry, Hansjörg Tschirky
  • Publication number: 20190022385
    Abstract: A sub-epidermal electric warning device has electrodes penetrating through the patient's epidermis and bipolar electric warning signals are transmitted to the sub-epidermal tissue by these electrodes. A device for surveillance of vital signs, analyte levels, or treatment parameters is using a sub-epidermal electric warning device for notifying the patient in situations requiring intervention.
    Type: Application
    Filed: July 20, 2018
    Publication date: January 24, 2019
    Applicant: PharmaSens AG
    Inventors: Paul Hadvary, Hansjorg Tschirky, Rudolf Dinger, Jean-Pierre Michot
  • Patent number: 10149974
    Abstract: A sub-epidermal electric warning device has electrodes penetrating through the patient's epidermis and bipolar electric warning signals are transmitted to the sub-epidermal tissue by these electrodes. A device for surveillance of vital signs, analyte levels, or treatment parameters is using a sub-epidermal electric warning device for notifying the patient in situations requiring intervention.
    Type: Grant
    Filed: June 12, 2013
    Date of Patent: December 11, 2018
    Assignee: PHARMASENS AG
    Inventors: Paul Hadvary, Hansjorg Tschirky, Rudolf Dinger, Jean-Pierre Michot
  • Patent number: 10130756
    Abstract: In a syringe type pump with a barrel (2) and a piston (4) movable in the interior of the barrel the barrel has the shape of a segment of a toroidal tube (2) and the piston is moved by means of a driving rod (6) which is guided and supported by the inner surface of the barrel wall. By the toroidal shape the overall size of the pump is significantly reduced and by guiding and supporting the driving rod of the piston by the inner surface of the barrel wall intrinsic problems of tightness, stick-slip phenomena and blockage are solved. A device for injecting fluid into a patient's body or removing body fluid therefrom is using a syringe type pump with a toroidal barrel and a driving rod of the piston guided and supported by the inner surface of the barrel wall.
    Type: Grant
    Filed: October 7, 2011
    Date of Patent: November 20, 2018
    Assignee: PharmaSens AG
    Inventors: Paul Hadváry, Hansjörg Tschirky
  • Patent number: 10117989
    Abstract: The subcutaneous injection device contains a pump and a mechanism for inserting a cannula into the patient's skin. The cannula is fixedly positioned relative to the pump and the insertion mechanism has a flexible surface adhering to the skin. The flexible surface is positioned relative to the cannula in such a way that in a first position the tip of the cannula is concealed by the surface and in a second position the cannula is exposed beyond the surface. The insertion mechanism brings the surface from the first to the second position, thereby pulling the skin against the tip of the cannula.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: November 6, 2018
    Assignee: PharmaSens AG
    Inventors: Pual Hadvary, Hansjorg Tschirky
  • Patent number: 10080582
    Abstract: A skin insertion mechanism includes a needle fixedly positioned in a needle holder with a connector (or connective means) to an injection or analysis system having a skin attachment plate coated with an adhesive layer and a spacer mechanism kept in the ready-to-use position, the skin attachment plate is spaced away from a needle support covering the needle. Subcutaneous insertion of the needle is effected by attachment of the adhesive layer to the skin and releasing the spacer mechanism by applying a pre-set trigger point pressure against the skin.
    Type: Grant
    Filed: April 8, 2013
    Date of Patent: September 25, 2018
    Assignee: PharmaSens AG
    Inventors: Paul Hadvary, Hansjorg Tschirky
  • Patent number: 10076356
    Abstract: A subcutaneous access device has a skin attachment plate coated with an adhesive layer. The skin attachment plate is moveably linked by a retraction mechanism to a needle support with fixedly positioned needles. In the ready-to-use position the skin attachment plate is spaced away from the needle support and covers the fixedly positioned needles. Subcutaneous insertion of the needles is effected by attachment of the skin attachment plate with the adhesive layer to the skin and releasing the retraction mechanism, thus triggering the pulling of the attached skin with high velocity against the tip of the needles.
    Type: Grant
    Filed: April 8, 2013
    Date of Patent: September 18, 2018
    Assignee: PharmaSens AG
    Inventors: Paul Hadvary, Hansjorg Tschirky
  • Publication number: 20160166763
    Abstract: In a device for ambulatory wearing by the patient containing a pump for delivery of injection fluid or for removal of analysis fluid, the drive motor for the mechanically driven pump system is a Lavet-type stepper motor of small size designed for having a high mechanical power and low peak current requirement. Using this Lavet-type motor for syringe-type or peristaltic preferably patch-type pumps high infusion rates needed for e.g. bolus insulin injection or the delivery of therapeutic antibodies are achieved, and important safety features can be easily and reliably controlled, manufacturing costs get significantly reduced, and the overall size and weight of the device becomes smaller, for patient convenience.
    Type: Application
    Filed: August 26, 2014
    Publication date: June 16, 2016
    Applicant: PHARMASENS AG
    Inventors: Paul Hadvary, Rudolf Dinger, Hansjorg Tschirky